Janney Montgomery Scott LLC Boosts Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Janney Montgomery Scott LLC lifted its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 14.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 33,341 shares of the company’s stock after acquiring an additional 4,130 shares during the period. Janney Montgomery Scott LLC’s holdings in IDEXX Laboratories were worth $18,506,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the company. Patron Partners LLC grew its holdings in shares of IDEXX Laboratories by 2.7% during the 4th quarter. Patron Partners LLC now owns 765 shares of the company’s stock worth $425,000 after purchasing an additional 20 shares during the period. NewEdge Wealth LLC raised its stake in shares of IDEXX Laboratories by 3.1% in the 4th quarter. NewEdge Wealth LLC now owns 659 shares of the company’s stock valued at $366,000 after acquiring an additional 20 shares during the period. Phoenix Holdings Ltd. lifted its holdings in shares of IDEXX Laboratories by 2.8% in the 3rd quarter. Phoenix Holdings Ltd. now owns 769 shares of the company’s stock worth $338,000 after acquiring an additional 21 shares during the last quarter. BluePath Capital Management LLC boosted its position in shares of IDEXX Laboratories by 1.8% during the 4th quarter. BluePath Capital Management LLC now owns 1,197 shares of the company’s stock worth $663,000 after purchasing an additional 21 shares during the period. Finally, Valley National Advisers Inc. increased its holdings in IDEXX Laboratories by 84.6% in the 4th quarter. Valley National Advisers Inc. now owns 48 shares of the company’s stock valued at $26,000 after purchasing an additional 22 shares during the last quarter. Hedge funds and other institutional investors own 87.84% of the company’s stock.

IDEXX Laboratories Stock Performance

Shares of IDXX opened at $540.94 on Friday. The company has a quick ratio of 1.16, a current ratio of 1.57 and a debt-to-equity ratio of 0.40. IDEXX Laboratories, Inc. has a 52-week low of $372.50 and a 52-week high of $583.39. The stock has a 50 day moving average price of $512.35 and a 200 day moving average price of $517.97. The company has a market capitalization of $44.68 billion, a price-to-earnings ratio of 52.37, a price-to-earnings-growth ratio of 4.32 and a beta of 1.27.

Analyst Ratings Changes

Several research firms recently issued reports on IDXX. StockNews.com upgraded IDEXX Laboratories from a “hold” rating to a “buy” rating in a report on Tuesday. JPMorgan Chase & Co. raised their price objective on shares of IDEXX Laboratories from $600.00 to $630.00 and gave the company an “overweight” rating in a research note on Tuesday, February 6th. Barclays dropped their price target on shares of IDEXX Laboratories from $655.00 to $570.00 and set an “overweight” rating for the company in a research note on Thursday, May 2nd. Morgan Stanley decreased their target price on IDEXX Laboratories from $620.00 to $596.00 and set an “overweight” rating for the company in a report on Tuesday. Finally, William Blair restated an “outperform” rating on shares of IDEXX Laboratories in a report on Tuesday, April 9th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $580.38.

About IDEXX Laboratories

IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.